At a glance
- Originator Abbott Laboratories
- Class Antidepressants; Benzofurans
- Mechanism of Action Alpha 2 adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 24 Aug 1998 No-Development-Reported for Depression in USA (Unknown route)
- 13 Aug 1996 Preclinical development for Depression in USA (Unknown route)